Smartleaf Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Buy
8,416
+804
+11% +$287K 0.11% 172
2025
Q4
$2.5M Buy
7,612
+751
+11% +$238K 0.09% 190
2025
Q3
$1.88M Buy
6,861
+1,831
+36% +$531K 0.12% 195
2025
Q2
$1.39M Sell
5,030
-493
-9% -$140K 0.12% 193
2025
Q1
$1.7M Buy
5,523
+612
+12% +$181K 0.16% 139
2024
Q4
$1.27M Buy
4,911
+469
+11% +$139K 0.13% 168
2024
Q3
$1.43M Buy
4,442
+1,390
+46% +$455K 0.17% 139
2024
Q2
$958K Buy
3,052
+420
+16% +$123K 0.16% 152
2024
Q1
$754K Buy
2,632
+328
+14% +$96K 0.15% 165
2023
Q4
$660K Buy
+2,304
New +$628K 0.18% 128

Other funds holding AMGN

Smartleaf Asset Management's AMGN Position: Q1 2026 in Review

Smartleaf Asset Management increased its Amgen (AMGN) stake by 11% in Q1 2026, buying an estimated $287K and bringing the position to 8,416 shares worth $2.94M. The position accounts for 0.11% of the portfolio, ranked #172.

Smartleaf Asset Management first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Smartleaf Asset Management held 8,416 shares of Amgen worth $2.94M as of Q1 2026.
  • Smartleaf Asset Management bought 804 Amgen shares in Q1 2026, an estimated $287K.
  • Amgen made up 0.11% of Smartleaf Asset Management's portfolio in Q1 2026, its #172 holding.
  • Smartleaf Asset Management first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.